HALO vs KYMR: stock comparison and AI forecast
Halozyme Therapeutics, Inc. (HALO) and Kymera Therapeutics, Inc. (KYMR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HALO Halozyme Therapeutics, Inc.
- Price
- $122.96 +88.6% · 6M
- Market Cap
- $13.96B
- P/E Ratio
- 24.9x
- Size
- large-cap
- AI Forecast
KYMR Kymera Therapeutics, Inc.
- Market Cap
- $10.94B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- HALO is 1.3 times larger than KYMR by market capitalization ($13.96B against $10.94B).
- HALO turns 26.9% of its revenue into net income, against -514.8% for KYMR.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HALO | KYMR |
|---|---|---|
| Market Cap | $13.96B | $10.94B |
| P/E Ratio | 24.94x | – |
| P/B Ratio | – | 6.77x |
| EPS | $4.93 | $-3.74 |
| Book Value/Share | – | $18.91 |
| Revenue/Share | $15.88 | $0.80 |
| FCF/Share | $7.81 | $-3.38 |
Profitability & Margins
| Metric | HALO | KYMR |
|---|---|---|
| ROE | – | -21.6% |
| ROA | 14.0% | -19.8% |
| ROIC | 22.5% | -24.1% |
| Gross Margin | 82.3% | 0.0% |
| Operating Margin | 37.4% | -596.6% |
| Net Margin | 26.9% | -514.8% |
| EBT Margin | 36.3% | -540.5% |
| Tax Rate | 25.9% | – |
Financial Health
| Metric | HALO | KYMR |
|---|---|---|
| Current Ratio | 3.88x | 11.13x |
| Quick Ratio | 3.60x | – |
| D/E Ratio | – | 0.09x |
| Financial Leverage | – | 1.09x |
| Interest Coverage | – | -3200.7x |
| Working Capital | $1.37B | $909M |
Cash Flow
| Metric | HALO | KYMR |
|---|---|---|
| Operating Cash Flow | $898M | -$288M |
| Free Cash Flow | $886M | -$289M |
| Capital Spending | -$12M | -$1M |
| OCF Growth YoY | 47.0% | – |
| FCF Growth YoY | 47.1% | – |
| FCF/Sales | 49.1% | -425.6% |
| CapEx/Sales | 0.7% | 2.0% |
Operational Efficiency
| Metric | HALO | KYMR |
|---|---|---|
| Asset Turnover | 0.52x | 0.04x |
| Receivables Turnover | 3.5x | – |
| Inventory Turnover | 2.4x | – |
| Fixed Assets Turnover | 35.2x | 1.8x |
| Days Sales Outstanding | 105 days | – |
| Days Inventory | 151 days | – |
| Payables Period | 38 days | 64 days |
| Cash Conversion Cycle | 218 days | – |
Income Statement
| Metric | HALO | KYMR |
|---|---|---|
| Total Revenue | $1.80B | $68M |
| Operating Income | $674M | -$405M |
| Net Income | $485M | -$349M |
| R&D Expense | $113M | $430M |
| SG&A Expense | $250M | – |
| Cost of Goods Sold | $320M | $68M |
Dividend & Shareholder Information
| Metric | HALO | KYMR |
|---|---|---|
| Shares Outstanding | 114M | 85M |
| Net Income Growth | -18.5% | – |
| EPS Growth | 11.5% | – |
HALO vs KYMR: stock comparison and AI forecast
Which is bigger, HALO or KYMR?
HALO is 1.3 times larger than KYMR by market capitalization ($13.96B against $10.94B).
Which one does Intratio's AI model rank higher, HALO or KYMR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.